Abstract
AbstractLittle is known about the impact of morphological disorders in distinct zones on metabolic zonation. It was described recently that periportal fibrosis did affect the expression of CYP proteins, a set of pericentrally located drug-metabolizing enzymes. Here, we investigated whether periportal steatosis might have a similar effect. Periportal steatosis was induced in C57BL6/J mice by feeding a high-fat diet with low methionine/choline content for either two or four weeks. Steatosis severity was quantified using image analysis. Triglycerides and CYP activity were quantified in photometric or fluorometric assay. The distribution of CYP3A4, CYP1A2, CYP2D6, and CYP2E1 was visualized by immunohistochemistry. Pharmacokinetic parameters of test drugs were determined after injecting a drug cocktail (caffeine, codeine, and midazolam). The dietary model resulted in moderate to severe mixed steatosis confined to periportal and midzonal areas. Periportal steatosis did not affect the zonal distribution of CYP expression but the activity of selected CYPs was associated with steatosis severity. Caffeine elimination was accelerated by microvesicular steatosis, whereas midazolam elimination was delayed in macrovesicular steatosis. In summary, periportal steatosis affected parameters of pericentrally located drug metabolism. This observation calls for further investigations of the highly complex interrelationship between steatosis and drug metabolism and underlying signaling mechanisms.
Funder
German Research Foundation (DFG), SteaPKMod
German Research Foundation (DFG), QuaLiPerF
Federal Ministry of Education and Research
German Research Foundation (DFG), SimLivA
Universitätsklinikum Jena
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Garza, A. Z., Park, S. B. & Kocz, R. Drug elimination. [Updated 2022 Jul 11]. In: StatPearls [Internet]. (StatPearls Publishing, 2022). https://www.ncbi.nlm.nih.gov/books/NBK547662/.
2. Almazroo, O. A., Miah, M. K. & Venkataramanan, R. Drug metabolism in the liver. Clin. Liver Dis. 21, 1. https://doi.org/10.1016/j.cld.2016.08.001 (2017).
3. Lindros, K. O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen. Pharmacol. 28, 191–196. https://doi.org/10.1016/s0306-3623(96)00183-8 (1997).
4. Colnot, S. & Perret, C. In Molecular Pathology of Liver Diseases 7–16 (Springer, 2011).
5. Soto-Gutierrez, A., Gough, A., Vernetti, L. A., Taylor, D. L. & Monga, S. P. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. Exp. Biol. Med. (Maywood) 242, 1605–1616. https://doi.org/10.1177/1535370217707731 (2017).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献